FORMULATION AND IN VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF VENLAFAXINE

http://dx.doi.org/10.31703/gpsr.2017(II-I).02      10.31703/gpsr.2017(II-I).02      Published : Dec 2017
Authored by : ZubairAnwar , TanveerAhmedKhan , MuhammadFarhanSohail , MaryamAnwar

02 Pages : 10-24

References

  • Aboelwafa, A. A., & Basalious, E. B. (2010). Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet. Aaps Pharmscitech, 11(3), 1026-1037.
  • AHMED, A., ALI, S. A., HASSAN, F., ALI, S. S., & HAQUE, N. (2001). Evaluation of acetaminophen tablets by control test. Pakistan journal of pharmaceutical sciences, 14(2), 47- 55.
  • Akash, M., Khan, I., Shah, S., Asghar, S., Massud, A., Qadir, M., & Akbar, A. (2010). Sustained release hydrophilic matrices based on xanthan gum and hydroxypropyl methylcellulose: development, optimization, in vitro and in vivo evaluation. J App Pharm, 4(2), 89-103.
  • Al-Saidan, S. M., Krishnaiah, Y. S., Patro, S., & Satyanaryana, V. (2005). In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride. Aaps Pharmscitech, 6(1), E14- E21.
  • Ali, L., Ahmad, M., & Usman, M. (2015). Evaluation of cross-linked hydroxypropyl methylcellulose graft-methacrylic acid copolymer as extended release oral drug carrier. Cell. Chem. Technol, 49(2), 143-151.
  • Ali, L., Ahmad, M., Usman, M., & Yousuf, M. (2014). Controlled release of highly water-soluble antidepressant from hybrid copolymer poly vinyl alcohol hydrogels. Polymer bulletin, 71(1), 31-46.
  • Ali, M., Singh, S., Kumar, A., Singh, S., Ansari, M., & Pattnaik, G. (2010). Preparation and in vitro evaluation of sustained release matrix tablets of phenytoin sodium using natural polymers. Int J Pharm Pharm Sci, 2(3), 174-179.
  • Allen, L., & Ansel, H. C. (2013). Ansel's pharmaceutical dosage forms and drug delivery systems: Lippincott Williams & Wilkins.
  • Amchin, J., Zarycranski, W., Taylor, K. P., Albano, D., & Klockowski, P. M. (1999). Effect of venlafaxine on the pharmacokinetics of risperidone. The Journal of Clinical Pharmacology, 39(3), 297-309.
  • Atul, A., & Prashant, Z. (2010). Designing and evaluation of extended release tablet of Venlafaxine hydrochloride using hydrophobic matrix. Der Pharmacia Lettre, 2(1), 329-335.
  • Avachat, A., Bornare, P., & Dash, R. (2011). Sustained release microspheres of ropinirole hydrochloride: effect of process parameters. Acta Pharmaceutica, 61(4), 363-376.
  • Bajdik, J., Pintye-Hódi, K., PlaninÅ¡ek, O., Regdon Jr, G., Srčič, S., & Erős, I. (2004). Film coating as a method to enhance the preparation of tablets from dimenhydrinate crystals. International journal of pharmaceutics, 269(2), 393-401.
  • Basak, S., Reddy, B. J., & Mani, K. L. (2006). Formulation and release behaviour of sustained release ambroxol hydrochloride HPMC matrix tablet. Indian Journal of Pharmaceutical Sciences, 68(5).
  • Brahmareddy, D., Madhulatha, A., & Priyanka, R. (2011). Formulation and Evaluation of Venlafaxine HCl Sustained Release Pellets.
  • Butani, S. B. (2013). Development and Optimization of Venlafaxine Hydrochloride Sustained Release Triple Layer Tablets Adopting Quality by Design Approach. Pharmacology & Pharmacy, 4(3A), 9-16.
  • Carignatto, C. R. R., Oliveira, K. S. M., de Lima, V. M. G., & de Oliva Neto, P. (2011). New culture medium to xanthan production by Xanthomonas campestris pv. campestris. Indian journal of microbiology, 51(3), 283-288.
  • Chandrasekhar, Y., Jaganathan, K., Senthil Selvi, R., Perumal, P., & Vani, T. (2011). Formulation and Invitro evaluation of didanosine sustained release matrix tablets using natural gums. Int J Res Pharm Biomed Sci, 2(1), 245-251.
  • Chirico, S., Dalmoro, A., Lamberti, G., Russo, G., & Titomanlio, G. (2007). Analysis and modeling of swelling and erosion behavior for pure HPMC tablet. Journal of Controlled Release, 122(2), 181-188.
  • Commission, B. P. (2011). British Pharmacopoeia 2009. Journal of Research and Education in Indian Medicine (Estt. 1982), 17(1), 64-64.
  • Conaghey, O., Corish, J., & Corrigan, O. (1998). Iontophoretically assisted in vitro membrane transport of nicotine from a hydrogel containing ion exchange resins. International journal of pharmaceutics, 170(2), 225-237.
  • Crowley, M. M., Schroeder, B., Fredersdorf, A., Obara, S., Talarico, M., Kucera, S., & McGinity, J. W. (2004). Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. International journal of pharmaceutics, 269(2), 509-522.
  • Dahmen, N., Marx, J., Hopf, H. C., Tettenborn, B., & Röder, R. (1999). Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke, 30(3), 691- 692.
  • Dastidar, S. G., Ganguly, K., Chaudhuri, K., & Chakrabarty, A. (2000). The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. International journal of antimicrobial agents, 14(3), 249-251.
  • Dineshmohan, S., Gupta, V., Ramesh, A., Harika, V., & Sravani, T. (2015). Effect of HPMC and ethyl cellulose polymeric granules and its combinations.
  • Durand, J., Deplanque, G., Montheil, V., Gornet, J., Scotte, F., Mir, O., . . . Mitry, E. (2011). Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Annals of Oncology, 23(1), 200-205.
  • Ford, J. L., Rubinstein, M. H., & Hogan, J. E. (1985). Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl- methylcellulose matrices. International journal of pharmaceutics, 24(2-3), 327-338.
  • Fukuda, M., Peppas, N. A., & McGinity, J. W. (2006). Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. International journal of pharmaceutics, 310(1-2), 90-100.
  • Gohel, M., Soni, C., Nagori, S., & Sarvaiya, K. (2008). Modulation of venlafaxine hydrochloride release from press coated matrix tablet. Indian Journal of Pharmaceutical Sciences, 70(3), 292.
  • Gupta, S., Singh, R. P., Sharma, R., Kalyanwat, R., & Lokwani, P. (2011). Osmotic pumps: A review. International journal of comprehensive pharmacy, 2(6), 1-8.
  • Hadi, M. A., Babu, V. L., & Pal, N. (2012). Formulation and evaluation of sustained releasematrix tablets of glimepiride based on combinationof hydrophilic and hydrophobic polymers.
  • Hanekamp, B., Zijlstra, J., Tulleken, J., Ligtenberg, J., Van Der Werf, T., & Hofstra, L. (2005). Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report. Neth J Med, 63(8), 316-318.
  • Hannan, N., Hamzah, Z., Akinpeloye, H. O., & Meagher, D. (2007). Venlafaxine - mirtazapine combination in the treatment of persistent depressive illness. Journal of Psychopharmacology, 21(2), 161-164.
  • Higuchi, T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of pharmaceutical sciences, 52(12), 1145-1149.
  • Howell, C., Wilson, A. D., & Waring, W. (2007). Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. British journal of clinical pharmacology, 64(2), 192-197.
  • Ilett, K. F., Kristensen, J. H., Hackett, L. P., Paech, M., Kohan, R., & Rampono, J. (2002). Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. British journal of clinical pharmacology, 53(1), 17-22.
  • Jain, A., Chauhan, R., Singh, S., Kulkarni, S., & Jain, S. (2015). OPTIMIZATION OF COATING MATERIAL FOR SUSTAINED RELEASE VENLAFAXINE HYDROCHLORIDE TABLET. INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 5(3), P1-P12.
  • Jain, N. K. (1997). Controlled and novel drug delivery: CBS publishers & distributors.
  • Jain, S., Yadav, S., & Patil, U. (2008). Preparation and evaluation of sustained release matrix tablet of furosemide using natural polymers. Research journal of pharmacy and technology, 1(4), 374- 376.
  • Kamboj, S., Gupta, G., & Oberoy, J. (2009). Matrix tablets: An important tool for oral controlled- release dosage forms. Pharmainfo. net, 7(6).
  • Kar, R., Mohapatra, S., & Barik, B. (2009). Design and characterization of controlled release matrix tablets of Zidovudine. Asian J Pharm Cli Res, 2(2), 54-61.
  • Kasper, S., Herman, B., Nivoli, G., Van Ameringen, M., Petralia, A., Mandel, F. S., . . . Bandelow, B. (2009). Efficacy of pregabalin and venlafaxine- XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. International clinical psychopharmacology, 24(2), 87-96.
  • Katzman, M. A., & Jacobs, L. (2007). Venlafaxine in the treatment of panic disorder. Neuropsychiatric disease and treatment, 3(1), 59.
  • Keny, R., Mankame, S., & Lourenco, C. (2009). Formulation and evaluation of once daily minocycline hydrochloride extended release matrix tablets. Indian Journal of Pharmaceutical Sciences, 71(3), 295.
  • Kumar, G., Gauri, S., Hooda, A., Saini, S., & Garg, A. (2011). Fabrication and evaluation of flavoured mucoadhesive buccal tablet of caffeine as CNS stimulant. Int. J. Universal Pharm. Life Sci, 1(2), 85-97.
  • Lachman, L., Lieberman, H. A., & Kanig, J. L. (1976). The theory and practice of industrial pharmacy: Lea & Febiger Philadelphia.
  • Lee, H., Kim, J. H., Min, B.-H., Lee, J. H., Son, H. J., Kim, J. J., . . . Rhee, P.-L. (2010). Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. The American journal of gastroenterology, 105(7), 1504.
  • Lieberman, H. A., & Lachman, L. (1980). Pharmaceutical Dosage Forms: Tablets: 1980 (Vol. 1): Marcel Dekker.
  • Maderich, A. B., & Sugita, E. T. (1996). Absorption enhancement of dextran sulfate after enteral administration in a dispersion. International journal of pharmaceutics, 137(1), 85-94.
  • Malipeddi, V. R., Awasthi, R., & Dua, K. (2016). Formulation and evaluation of controlled release ethylcellulose and polyethylene glycol microspheres containing metoprolol tartrate. Interventional Medicine and Applied Science, 8(2), 60-67.
  • Mamidala, R. K., Ramana, V., Sandeep, G., Lingam, M., Gannu, R., & Yamsani, M. R. (2009). Factors influencing the design and performance of oral sustained/controlled release dosage forms. Int. J. Pharm. Sci. and Nanotech, 2(3), 583-594.
  • Mehta, P., Deshmukh, G. J., Seth, A., & Banty, P. (2011). Formulation and evaluation of sustained release matrix tablets of captopril. Indo American Journal of Pharmaceutical Research, 1(6), 69-83.
  • Moin, A., & Shivakumar, H. (2010). Formulation of sustained-release diltiazem matrix tablets using hydrophilic gum blends. Tropical Journal of Pharmaceutical Research, 9(3).
  • Moosavi-Nasab, M., Pashangeh, S., & Rafsanjani, M. (2010). Effect of fermentation time on xanthan gum production from sugar beet molasses. World Academy of Science, Engineering and Technology, 4, 1018-1021.
  • Mughal, M. A., Iqbal, Z., & Neau, S. H. (2011). Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride. Aaps Pharmscitech, 12(1), 77-87.
  • NAKABAYASHI, K., SHIMAMOTO, T., & MIMA, H. (1980). Stability of packaged solid dosage forms. I. Shelf-life prediction for packaged tablets liable to moisture damage. Chemical and Pharmaceutical Bulletin, 28(4), 1090-1098.
  • Nokhodchi, A., Raja, S., Patel, P., & Asare-Addo, K. (2012). The role of oral controlled release matrix tablets in drug delivery systems. BioImpacts: BI, 2(4), 175.
  • Patel, J., & Shah, N. Formulation and Evaluation of Sustained Release Tablets Containing Atomoxetine Hydrochloride.
  • Patil, S., Kulkarni, U., & Bhavik, P. (2010). Formulation and evaluation of diclofenac potassium matrix tablets. International Journal of Pharmaceutical Sciences and Research, 1(8), 88-92.
  • Peppas, N. A., & Sahlin, J. J. (1989). A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. International journal of pharmaceutics, 57(2), 169-172.
  • PINEDA, E. A. G., & Hechenleitner, A. (2004). Characterization of ethylcellulose films containing natural polysaccharides by thermal analysis and FTIR spectroscopy. Acta Farm. Bonaerense, 23(1), 53-57.
  • Prescott, J. K., & HOOSFELD, R. (1994). Maintaining product uniformity and uninterrupted flow to direct-compression tableting presses. Pharmaceutical technology, 18(6), 98-98.
  • Priya, C., & Rajkumari, K. A. INTERNATIONAL RESEARCH JOURNAL OF PHARMACY.
  • Rajendran, N., Natarajan, R., Subhashini, R., & Patel, H. (2011). Formulation and evaluation of sustained release bilayer tablets of metformin HCl and pioglitazone HCl. Int J Curr Pharm Res, 3(3), 118-122.
  • Rajesh, K., Venkataraju, M., & Gowda, D. (2009). Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride. Pakistan journal of pharmaceutical sciences, 22(2).
  • Ranjha, N. M., Madni, A., Bakar, A. A., Talib, N., Ahmad, S., & Ahmad, H. (2014). Preparation and characterization of isosorbide mononitrate hydrogels obtained by free-radical polymerization for site-specific delivery. Tropical Journal of Pharmaceutical Research, 13(12), 1979-1985.
  • Robinson, J., & Lee, V. H. (1987). Controlled drug delivery: fundamentals and applications: CRC Press.
  • Rodríguez, H., & Aguilar, L. (1997). Detection of Xanthomonas campestris mutants with increased xanthan production. Journal of Industrial Microbiology and Biotechnology, 18(4), 232-234.
  • Salger, S. V., Danki, L. S., Hiremath, S., & Sayeed, A. (2010). Preparation and evaluation of sustained release matrix tablets of propranolol hydrochloride. International journal of pharma and bio sciences, 1(4), 227-241.
  • Salsa, T., Veiga, F., & Pina, M. (1997). Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Development and Industrial Pharmacy, 23(9), 929-938.
  • Senthilnathan, B., & Rupenagunta, A. (2011). Formulation development and evaluation of venlafaxine hydrochloride orodispersible tablets. International Journal of Pharmaceutical Sciences and Research, 2(4), 913.
  • Shah, S. N. H., Asghar, S., Choudhry, M. A., Akash, M. S. H., Rehman, N. u., & Baksh, S. (2009). Formulation and evaluation of natural gum- based sustained release matrix tablets of flurbiprofen using response surface methodology. Drug Development and Industrial Pharmacy, 35(12), 1470-1478.
  • Shaikh, A., Shaikh, P., Pawar, Y., Kumbhar, S., & Katedeshmukh, R. (2011). Effect of gums and excipients on drug release of ambroxol-HCl sustained release matrices. J Curr Pharm Res, 6(1), 11-15.
  • Shanmugarathinam, A., & Puratchikody, A. (2014). Formulation and Characterization of Ritonavir loaded Ethylcellulose Buoyant Microspheres. Journal of Pharmaceutical Sciences and Research, 6(8), 274-277.
  • Siepmann, J., & Peppas, N. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Advanced drug delivery reviews, 48(2-3), 139- 157.
  • Singhvi, G., & Singh, M. (2011). In-vitro drug release characterization models. International Journal of Pharmacutical Studies and Research, 2, 77- 84.
  • Urbán-Morlán, Z., Mendoza-Elvira, S. E., Hernández- Cerón, R. S., Alcalá-Alcalá, S., Ramírez- Mendoza, H., Ciprián-Carrasco, A., . . . Quintanar-Guerrero, D. (2015). Preparation of ethyl cellulose nanoparticles by solvent- displacement using the conventional method and a recirculation system. Journal of the Mexican Chemical Society, 59(3), 173-180
  • Varshosaz, J., Tavakoli, N., & Kheirolahi, F. (2006). Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. Aaps Pharmscitech, 7(1), E168- E174.
  • Verma, N. K., Alam, G., Mishra, J., Vishwakarma, D., & Singh, V. K. Formulation development and characterization of ethyl cellulose microspheres of ibuprofen.

References

  • Aboelwafa, A. A., & Basalious, E. B. (2010). Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet. Aaps Pharmscitech, 11(3), 1026-1037.
  • AHMED, A., ALI, S. A., HASSAN, F., ALI, S. S., & HAQUE, N. (2001). Evaluation of acetaminophen tablets by control test. Pakistan journal of pharmaceutical sciences, 14(2), 47- 55.
  • Akash, M., Khan, I., Shah, S., Asghar, S., Massud, A., Qadir, M., & Akbar, A. (2010). Sustained release hydrophilic matrices based on xanthan gum and hydroxypropyl methylcellulose: development, optimization, in vitro and in vivo evaluation. J App Pharm, 4(2), 89-103.
  • Al-Saidan, S. M., Krishnaiah, Y. S., Patro, S., & Satyanaryana, V. (2005). In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride. Aaps Pharmscitech, 6(1), E14- E21.
  • Ali, L., Ahmad, M., & Usman, M. (2015). Evaluation of cross-linked hydroxypropyl methylcellulose graft-methacrylic acid copolymer as extended release oral drug carrier. Cell. Chem. Technol, 49(2), 143-151.
  • Ali, L., Ahmad, M., Usman, M., & Yousuf, M. (2014). Controlled release of highly water-soluble antidepressant from hybrid copolymer poly vinyl alcohol hydrogels. Polymer bulletin, 71(1), 31-46.
  • Ali, M., Singh, S., Kumar, A., Singh, S., Ansari, M., & Pattnaik, G. (2010). Preparation and in vitro evaluation of sustained release matrix tablets of phenytoin sodium using natural polymers. Int J Pharm Pharm Sci, 2(3), 174-179.
  • Allen, L., & Ansel, H. C. (2013). Ansel's pharmaceutical dosage forms and drug delivery systems: Lippincott Williams & Wilkins.
  • Amchin, J., Zarycranski, W., Taylor, K. P., Albano, D., & Klockowski, P. M. (1999). Effect of venlafaxine on the pharmacokinetics of risperidone. The Journal of Clinical Pharmacology, 39(3), 297-309.
  • Atul, A., & Prashant, Z. (2010). Designing and evaluation of extended release tablet of Venlafaxine hydrochloride using hydrophobic matrix. Der Pharmacia Lettre, 2(1), 329-335.
  • Avachat, A., Bornare, P., & Dash, R. (2011). Sustained release microspheres of ropinirole hydrochloride: effect of process parameters. Acta Pharmaceutica, 61(4), 363-376.
  • Bajdik, J., Pintye-Hódi, K., PlaninÅ¡ek, O., Regdon Jr, G., Srčič, S., & Erős, I. (2004). Film coating as a method to enhance the preparation of tablets from dimenhydrinate crystals. International journal of pharmaceutics, 269(2), 393-401.
  • Basak, S., Reddy, B. J., & Mani, K. L. (2006). Formulation and release behaviour of sustained release ambroxol hydrochloride HPMC matrix tablet. Indian Journal of Pharmaceutical Sciences, 68(5).
  • Brahmareddy, D., Madhulatha, A., & Priyanka, R. (2011). Formulation and Evaluation of Venlafaxine HCl Sustained Release Pellets.
  • Butani, S. B. (2013). Development and Optimization of Venlafaxine Hydrochloride Sustained Release Triple Layer Tablets Adopting Quality by Design Approach. Pharmacology & Pharmacy, 4(3A), 9-16.
  • Carignatto, C. R. R., Oliveira, K. S. M., de Lima, V. M. G., & de Oliva Neto, P. (2011). New culture medium to xanthan production by Xanthomonas campestris pv. campestris. Indian journal of microbiology, 51(3), 283-288.
  • Chandrasekhar, Y., Jaganathan, K., Senthil Selvi, R., Perumal, P., & Vani, T. (2011). Formulation and Invitro evaluation of didanosine sustained release matrix tablets using natural gums. Int J Res Pharm Biomed Sci, 2(1), 245-251.
  • Chirico, S., Dalmoro, A., Lamberti, G., Russo, G., & Titomanlio, G. (2007). Analysis and modeling of swelling and erosion behavior for pure HPMC tablet. Journal of Controlled Release, 122(2), 181-188.
  • Commission, B. P. (2011). British Pharmacopoeia 2009. Journal of Research and Education in Indian Medicine (Estt. 1982), 17(1), 64-64.
  • Conaghey, O., Corish, J., & Corrigan, O. (1998). Iontophoretically assisted in vitro membrane transport of nicotine from a hydrogel containing ion exchange resins. International journal of pharmaceutics, 170(2), 225-237.
  • Crowley, M. M., Schroeder, B., Fredersdorf, A., Obara, S., Talarico, M., Kucera, S., & McGinity, J. W. (2004). Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. International journal of pharmaceutics, 269(2), 509-522.
  • Dahmen, N., Marx, J., Hopf, H. C., Tettenborn, B., & Röder, R. (1999). Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke, 30(3), 691- 692.
  • Dastidar, S. G., Ganguly, K., Chaudhuri, K., & Chakrabarty, A. (2000). The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. International journal of antimicrobial agents, 14(3), 249-251.
  • Dineshmohan, S., Gupta, V., Ramesh, A., Harika, V., & Sravani, T. (2015). Effect of HPMC and ethyl cellulose polymeric granules and its combinations.
  • Durand, J., Deplanque, G., Montheil, V., Gornet, J., Scotte, F., Mir, O., . . . Mitry, E. (2011). Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Annals of Oncology, 23(1), 200-205.
  • Ford, J. L., Rubinstein, M. H., & Hogan, J. E. (1985). Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl- methylcellulose matrices. International journal of pharmaceutics, 24(2-3), 327-338.
  • Fukuda, M., Peppas, N. A., & McGinity, J. W. (2006). Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. International journal of pharmaceutics, 310(1-2), 90-100.
  • Gohel, M., Soni, C., Nagori, S., & Sarvaiya, K. (2008). Modulation of venlafaxine hydrochloride release from press coated matrix tablet. Indian Journal of Pharmaceutical Sciences, 70(3), 292.
  • Gupta, S., Singh, R. P., Sharma, R., Kalyanwat, R., & Lokwani, P. (2011). Osmotic pumps: A review. International journal of comprehensive pharmacy, 2(6), 1-8.
  • Hadi, M. A., Babu, V. L., & Pal, N. (2012). Formulation and evaluation of sustained releasematrix tablets of glimepiride based on combinationof hydrophilic and hydrophobic polymers.
  • Hanekamp, B., Zijlstra, J., Tulleken, J., Ligtenberg, J., Van Der Werf, T., & Hofstra, L. (2005). Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report. Neth J Med, 63(8), 316-318.
  • Hannan, N., Hamzah, Z., Akinpeloye, H. O., & Meagher, D. (2007). Venlafaxine - mirtazapine combination in the treatment of persistent depressive illness. Journal of Psychopharmacology, 21(2), 161-164.
  • Higuchi, T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of pharmaceutical sciences, 52(12), 1145-1149.
  • Howell, C., Wilson, A. D., & Waring, W. (2007). Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. British journal of clinical pharmacology, 64(2), 192-197.
  • Ilett, K. F., Kristensen, J. H., Hackett, L. P., Paech, M., Kohan, R., & Rampono, J. (2002). Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. British journal of clinical pharmacology, 53(1), 17-22.
  • Jain, A., Chauhan, R., Singh, S., Kulkarni, S., & Jain, S. (2015). OPTIMIZATION OF COATING MATERIAL FOR SUSTAINED RELEASE VENLAFAXINE HYDROCHLORIDE TABLET. INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 5(3), P1-P12.
  • Jain, N. K. (1997). Controlled and novel drug delivery: CBS publishers & distributors.
  • Jain, S., Yadav, S., & Patil, U. (2008). Preparation and evaluation of sustained release matrix tablet of furosemide using natural polymers. Research journal of pharmacy and technology, 1(4), 374- 376.
  • Kamboj, S., Gupta, G., & Oberoy, J. (2009). Matrix tablets: An important tool for oral controlled- release dosage forms. Pharmainfo. net, 7(6).
  • Kar, R., Mohapatra, S., & Barik, B. (2009). Design and characterization of controlled release matrix tablets of Zidovudine. Asian J Pharm Cli Res, 2(2), 54-61.
  • Kasper, S., Herman, B., Nivoli, G., Van Ameringen, M., Petralia, A., Mandel, F. S., . . . Bandelow, B. (2009). Efficacy of pregabalin and venlafaxine- XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. International clinical psychopharmacology, 24(2), 87-96.
  • Katzman, M. A., & Jacobs, L. (2007). Venlafaxine in the treatment of panic disorder. Neuropsychiatric disease and treatment, 3(1), 59.
  • Keny, R., Mankame, S., & Lourenco, C. (2009). Formulation and evaluation of once daily minocycline hydrochloride extended release matrix tablets. Indian Journal of Pharmaceutical Sciences, 71(3), 295.
  • Kumar, G., Gauri, S., Hooda, A., Saini, S., & Garg, A. (2011). Fabrication and evaluation of flavoured mucoadhesive buccal tablet of caffeine as CNS stimulant. Int. J. Universal Pharm. Life Sci, 1(2), 85-97.
  • Lachman, L., Lieberman, H. A., & Kanig, J. L. (1976). The theory and practice of industrial pharmacy: Lea & Febiger Philadelphia.
  • Lee, H., Kim, J. H., Min, B.-H., Lee, J. H., Son, H. J., Kim, J. J., . . . Rhee, P.-L. (2010). Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. The American journal of gastroenterology, 105(7), 1504.
  • Lieberman, H. A., & Lachman, L. (1980). Pharmaceutical Dosage Forms: Tablets: 1980 (Vol. 1): Marcel Dekker.
  • Maderich, A. B., & Sugita, E. T. (1996). Absorption enhancement of dextran sulfate after enteral administration in a dispersion. International journal of pharmaceutics, 137(1), 85-94.
  • Malipeddi, V. R., Awasthi, R., & Dua, K. (2016). Formulation and evaluation of controlled release ethylcellulose and polyethylene glycol microspheres containing metoprolol tartrate. Interventional Medicine and Applied Science, 8(2), 60-67.
  • Mamidala, R. K., Ramana, V., Sandeep, G., Lingam, M., Gannu, R., & Yamsani, M. R. (2009). Factors influencing the design and performance of oral sustained/controlled release dosage forms. Int. J. Pharm. Sci. and Nanotech, 2(3), 583-594.
  • Mehta, P., Deshmukh, G. J., Seth, A., & Banty, P. (2011). Formulation and evaluation of sustained release matrix tablets of captopril. Indo American Journal of Pharmaceutical Research, 1(6), 69-83.
  • Moin, A., & Shivakumar, H. (2010). Formulation of sustained-release diltiazem matrix tablets using hydrophilic gum blends. Tropical Journal of Pharmaceutical Research, 9(3).
  • Moosavi-Nasab, M., Pashangeh, S., & Rafsanjani, M. (2010). Effect of fermentation time on xanthan gum production from sugar beet molasses. World Academy of Science, Engineering and Technology, 4, 1018-1021.
  • Mughal, M. A., Iqbal, Z., & Neau, S. H. (2011). Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride. Aaps Pharmscitech, 12(1), 77-87.
  • NAKABAYASHI, K., SHIMAMOTO, T., & MIMA, H. (1980). Stability of packaged solid dosage forms. I. Shelf-life prediction for packaged tablets liable to moisture damage. Chemical and Pharmaceutical Bulletin, 28(4), 1090-1098.
  • Nokhodchi, A., Raja, S., Patel, P., & Asare-Addo, K. (2012). The role of oral controlled release matrix tablets in drug delivery systems. BioImpacts: BI, 2(4), 175.
  • Patel, J., & Shah, N. Formulation and Evaluation of Sustained Release Tablets Containing Atomoxetine Hydrochloride.
  • Patil, S., Kulkarni, U., & Bhavik, P. (2010). Formulation and evaluation of diclofenac potassium matrix tablets. International Journal of Pharmaceutical Sciences and Research, 1(8), 88-92.
  • Peppas, N. A., & Sahlin, J. J. (1989). A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. International journal of pharmaceutics, 57(2), 169-172.
  • PINEDA, E. A. G., & Hechenleitner, A. (2004). Characterization of ethylcellulose films containing natural polysaccharides by thermal analysis and FTIR spectroscopy. Acta Farm. Bonaerense, 23(1), 53-57.
  • Prescott, J. K., & HOOSFELD, R. (1994). Maintaining product uniformity and uninterrupted flow to direct-compression tableting presses. Pharmaceutical technology, 18(6), 98-98.
  • Priya, C., & Rajkumari, K. A. INTERNATIONAL RESEARCH JOURNAL OF PHARMACY.
  • Rajendran, N., Natarajan, R., Subhashini, R., & Patel, H. (2011). Formulation and evaluation of sustained release bilayer tablets of metformin HCl and pioglitazone HCl. Int J Curr Pharm Res, 3(3), 118-122.
  • Rajesh, K., Venkataraju, M., & Gowda, D. (2009). Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride. Pakistan journal of pharmaceutical sciences, 22(2).
  • Ranjha, N. M., Madni, A., Bakar, A. A., Talib, N., Ahmad, S., & Ahmad, H. (2014). Preparation and characterization of isosorbide mononitrate hydrogels obtained by free-radical polymerization for site-specific delivery. Tropical Journal of Pharmaceutical Research, 13(12), 1979-1985.
  • Robinson, J., & Lee, V. H. (1987). Controlled drug delivery: fundamentals and applications: CRC Press.
  • Rodríguez, H., & Aguilar, L. (1997). Detection of Xanthomonas campestris mutants with increased xanthan production. Journal of Industrial Microbiology and Biotechnology, 18(4), 232-234.
  • Salger, S. V., Danki, L. S., Hiremath, S., & Sayeed, A. (2010). Preparation and evaluation of sustained release matrix tablets of propranolol hydrochloride. International journal of pharma and bio sciences, 1(4), 227-241.
  • Salsa, T., Veiga, F., & Pina, M. (1997). Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Development and Industrial Pharmacy, 23(9), 929-938.
  • Senthilnathan, B., & Rupenagunta, A. (2011). Formulation development and evaluation of venlafaxine hydrochloride orodispersible tablets. International Journal of Pharmaceutical Sciences and Research, 2(4), 913.
  • Shah, S. N. H., Asghar, S., Choudhry, M. A., Akash, M. S. H., Rehman, N. u., & Baksh, S. (2009). Formulation and evaluation of natural gum- based sustained release matrix tablets of flurbiprofen using response surface methodology. Drug Development and Industrial Pharmacy, 35(12), 1470-1478.
  • Shaikh, A., Shaikh, P., Pawar, Y., Kumbhar, S., & Katedeshmukh, R. (2011). Effect of gums and excipients on drug release of ambroxol-HCl sustained release matrices. J Curr Pharm Res, 6(1), 11-15.
  • Shanmugarathinam, A., & Puratchikody, A. (2014). Formulation and Characterization of Ritonavir loaded Ethylcellulose Buoyant Microspheres. Journal of Pharmaceutical Sciences and Research, 6(8), 274-277.
  • Siepmann, J., & Peppas, N. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Advanced drug delivery reviews, 48(2-3), 139- 157.
  • Singhvi, G., & Singh, M. (2011). In-vitro drug release characterization models. International Journal of Pharmacutical Studies and Research, 2, 77- 84.
  • Urbán-Morlán, Z., Mendoza-Elvira, S. E., Hernández- Cerón, R. S., Alcalá-Alcalá, S., Ramírez- Mendoza, H., Ciprián-Carrasco, A., . . . Quintanar-Guerrero, D. (2015). Preparation of ethyl cellulose nanoparticles by solvent- displacement using the conventional method and a recirculation system. Journal of the Mexican Chemical Society, 59(3), 173-180
  • Varshosaz, J., Tavakoli, N., & Kheirolahi, F. (2006). Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. Aaps Pharmscitech, 7(1), E168- E174.
  • Verma, N. K., Alam, G., Mishra, J., Vishwakarma, D., & Singh, V. K. Formulation development and characterization of ethyl cellulose microspheres of ibuprofen.

Cite this article

APA

    APA : Anwar, Z., Khan, T. A., & Sohail, M. F. (2017). Formulation and In Vitro Evaluation of Sustained Release Matrix Tablets of Venlafaxine. Global Pharmaceutical Sciences Review, II(I), 10-24. https://doi.org/10.31703/gpsr.2017(II-I).02

CHICAGO

    CHICAGO : Anwar, Zubair, Tanveer Ahmed Khan, and Muhammad Farhan Sohail. 2017. "Formulation and In Vitro Evaluation of Sustained Release Matrix Tablets of Venlafaxine." Global Pharmaceutical Sciences Review, II (I): 10-24 doi: 10.31703/gpsr.2017(II-I).02

HARVARD

    HARVARD : ANWAR, Z., KHAN, T. A. & SOHAIL, M. F. 2017. Formulation and In Vitro Evaluation of Sustained Release Matrix Tablets of Venlafaxine. Global Pharmaceutical Sciences Review, II, 10-24.

MHRA

    MHRA : Anwar, Zubair, Tanveer Ahmed Khan, and Muhammad Farhan Sohail. 2017. "Formulation and In Vitro Evaluation of Sustained Release Matrix Tablets of Venlafaxine." Global Pharmaceutical Sciences Review, II: 10-24

MLA

    MLA : Anwar, Zubair, Tanveer Ahmed Khan, and Muhammad Farhan Sohail. "Formulation and In Vitro Evaluation of Sustained Release Matrix Tablets of Venlafaxine." Global Pharmaceutical Sciences Review, II.I (2017): 10-24 Print.

OXFORD

    OXFORD : Anwar, Zubair, Khan, Tanveer Ahmed, and Sohail, Muhammad Farhan (2017), "Formulation and In Vitro Evaluation of Sustained Release Matrix Tablets of Venlafaxine", Global Pharmaceutical Sciences Review, II (I), 10-24

TURABIAN

    TURABIAN : Anwar, Zubair, Tanveer Ahmed Khan, and Muhammad Farhan Sohail. "Formulation and In Vitro Evaluation of Sustained Release Matrix Tablets of Venlafaxine." Global Pharmaceutical Sciences Review II, no. I (2017): 10-24. https://doi.org/10.31703/gpsr.2017(II-I).02